Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.

Home Research Research Publication Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.

Gillies MC, Hunyor AP, Arnold JJ, Guymer RH, Wolf S, Ng P, Pecheur FL, McAllister IL.

JAMA Ophthalmol. 2019 Jan 24. doi: 10.1001/jamaophthalmol.2018.6776. [Epub ahead of print]

PMID: 30676617 IF 6.167

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

(08) 9381 0777

carecentre@lei.org.au

Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.

Need any help?

Request an appointment